This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Albireo Pharma
ALBO
$44.15
Share price
0.00%
Change (1 day)
118.89%
Change (1 year)
Categories
Albireo Pharma (ALBO) - Total debt
Total debt on the balance sheet as of June 2022 : $10.15 Million USD
According to Albireo Pharma's latest financial reports the company's total debt is $10.15 Million USD. A company’s total debt is the sum of all current and non-current debts.
Albireo Pharma - Total debt on balance sheet (from 2010 to 2022)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2021-12-31 | $10 M | 3.98% |
| 2020-12-31 | $9.62 M | |
| 2016-12-31 | $3.07 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | $3.18 M | -68.67% | 🇺🇸 USA |